Anita Gola

Anita Gola

Auto-generated profile, based on publicly available information

Anita Gola

Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2020 in Nature
Verified
Journal Article
Closed access
PDF file
AGAnita Gola
Anita Gola
MDMichael G. Dorrington
Michael G. Dorrington
ESEmily Speranza
Emily Speranza
CSClaudia Sala
Claudia Sala
RSRochelle M. Shih
Rochelle M. Shih
RGRonald N. Germain
Ronald N. Germain

26 November 2021 in Science
Verified
Journal Article
Closed access
KGKevin Andrew Uy Gonzales
Kevin Andrew Uy Gonzales
LPLisa Polak
Lisa Polak
IMIrina Matos
Irina Matos
MTMatthew T. Tierney
Matthew T. Tierney
AGAnita Gola
Anita Gola
EFElaine Fuchs
Elaine Fuchs
Stem cells remember: Tissue stem cells sense their surroundings, and this perception influences subsequent fate and function. Gonzales et al . observed that stem cells accumulate epigenetic memories of diverse environmental events (see the Perspective by Hoste). By wounding skin and monitoring the temporal steps involved in mobilizing stem cells of the hair follicle to repair the epidermis, the authors found that stem cells bear memories of their original niche, migration, encounters with inflammation, and adaptation to the new fate and tasks. During homeostasis, immigrant stem cells are functionally and transcriptionally analogous to native cells, but upon future assaults, they unleash discrete epigenetic memories to heighten physiological response and affect tissue fitness. —BAP

31 January 2021 in Current Opinion in Cell Biology
Verified
Journal Article
Closed access
AGAnita Gola
Anita Gola
EFElaine Fuchs
Elaine Fuchs

9 August 2021 in Nature
Verified
Journal Article
Closed access
PDF file
AGAnita Gola
Anita Gola
MDMichael G. Dorrington
Michael G. Dorrington
ESEmily Speranza
Emily Speranza
CSClaudia Sala
Claudia Sala
RSRochelle M. Shih
Rochelle M. Shih
RGRonald N. Germain
Ronald N. Germain

24 October 2022 in Nature
Verified
Journal Article
Closed access
PDF file
AGAnita Gola
Anita Gola
MDMichael G. Dorrington
Michael G. Dorrington
ESEmily Speranza
Emily Speranza
CSClaudia Sala
Claudia Sala
RSRochelle M. Shih
Rochelle M. Shih
RGRonald N. Germain
Ronald N. Germain

7 July 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
HIHiroshi Ichise
Hiroshi Ichise
ESEmily Speranza
Emily Speranza
FRFederica La Russa
Federica La Russa
TVTibor Z. Veres
Tibor Z. Veres
CCColin J. Chu
Colin J. Chu
RGRonald N. Germain
Ronald N. Germain
Maintaining tissue function while eliminating infected cells is fundamental to host defense. Innate inflammatory damage contributes to lethal influenza and COVID-19, yet other than steroids, immunomodulatory drugs have modest effects. Among more than 50 immunomodulatory regimes tested in mouse lethal influenza infection, only the previously reported early depletion of neutrophils showed efficacy, suggesting that the infected host passes an early tipping point in which limiting innate immune damage alone cannot rescue physiological function. To re-balance the system late in infection, we investigated whether partial limitation of viral spread using oseltamivir (Tamiflu) together with enhancement of epithelial repair by blockade of interferon signaling or the limitation of further epithelial cell loss mediated by cytotoxic CD8 + T cells would prevent death. These treatments salvaged a large fraction of infected animals, providing new insight into the importance of repair processes and the timing of adaptive immune responses in survival of pulmonary infections.